Similar medications and substitutes for ISATUXIMAB
In short: Sarclisa (ISATUXIMAB) belongs to the CD38-directed Cytolytic Antibody class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Sarclisa is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Sarclisa in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.